This is highly consistent with the results of differential expression analysis, suggesting that IGF2BP2 and IGF2BP3 may have an important role in the development of ESCC, which needs to be further explored in larger cohort. This evidence concerns the gene IGF2BP2 and esophageal squamous cell carcinoma.